As of 2026-04-05, the EV/EBITDA ratio of Intra-Cellular Therapies Inc (ITCI) is -118.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ITCI's latest enterprise value is 13,739.84 mil USD. ITCI's TTM EBITDA according to its financial statements is -116.21 mil USD. Dividing these 2 quantities gives us the above ITCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 14.8x | 11.7x |
| Forward P/E multiples | 12.6x - 14.1x | 12.8x |
| Fair Price | (10.91) - (12.50) | (10.51) |
| Upside | -108.3% - -109.5% | -108.0% |
| Date | EV/EBITDA |